Burjeel Holdings opens IPO at AED 14 billion valuation on Abu Dhabi exchange

Burjeel Holdings opened its IPO subscription on 30 September 2022, offering about 11% of shares at AED 1.95–2.00 each on the Abu Dhabi Securities Exchange (ADX). At the top of the range, the deal values the company at roughly AED 14 billion, one of the largest healthcare listings in the Middle East.

The subscription period runs through mid-October, with trading expected to begin in the second half of that month. Final pricing and allocation details will follow the close of subscriptions.

What the listing means for UAE healthcare

Burjeel operates more than 40 healthcare facilities across the UAE and Oman, including Burjeel Medical City in Abu Dhabi and a network of hospitals, medical centres, and pharmacies. Founder and chairman Dr. Shamsheer Vayalil built the group from a single clinic in 2007 into a multi-brand platform that covers primary care through quaternary services.

The IPO arrives during accelerating consolidation in Gulf healthcare. Pure Health, backed by Abu Dhabi's sovereign wealth apparatus, has been acquiring hospital groups across the emirate. Mediclinic Middle East and NMC Health's successor entities continue restructuring after the NMC accounting scandal. A public listing gives Burjeel a currency for acquisitions and a signal to competitors that it intends to keep buying.

Abu Dhabi's Department of Health (DOH) has expanded mandatory health insurance coverage and tightened facility licensing standards, a regulatory setup that rewards well-capitalised operators. The emirate's population grew 4.2% in 2022, driven by visa reforms and economic diversification. More residents means more demand for hospital beds and outpatient capacity.

Financial profile and use of proceeds

Burjeel reported revenues of approximately AED 4.1 billion for the 12 months before the offering. The UAE accounted for around 85% of group revenue. The company has been investing in higher-acuity services (oncology, cardiology, orthopaedics), which carry stronger margins than general outpatient care.

Proceeds from the IPO are expected to fund:

• Expansion of specialist capacity at Burjeel Medical City in Abu Dhabi
• Debt reduction across the group's existing facility portfolio
• Potential acquisitions of smaller clinic networks in the Northern Emirates and Oman

Joint global coordinators and bookrunners on the deal are Abu Dhabi Commercial Bank, Citigroup, EFG Hermes, and Morgan Stanley.

What operators should watch

Burjeel's IPO sets a public benchmark for private hospital valuations in the UAE. CFOs at competing groups now have a market-derived multiple against which to measure their own portfolios. The listing also puts pressure on mid-sized operators who lack capital to match Burjeel's investment in specialist infrastructure and technology.

DOH's regulatory direction rewards scale. Its Jawda quality programme and upcoming data-sharing mandates require IT spending that smaller operators may struggle to fund on their own. Burjeel's access to public capital markets widens the gap between large platforms and independent clinics.